Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Appointed director
|
|
RELMADA THERAPEUTICS, INC. (RLMD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/25/2023 |
8-K
| Appointed a new director |
| 06/01/2022 |
8-K
| Quarterly results |
| 05/20/2021 |
8-K
| Quarterly results |
| 08/07/2015 |
8-K
| Appointed a new director|
Docs:
|
"Amended and Restated Bylaws of Relmada Therapeutics, Inc",
"Amendment to the Relmada Therapeutics, Inc. 2014 Stock Option and Equity Incentive Plan",
"Form of Indemnification Agreement",
"Termination Agreement, by and between Relmada Therapeutics, Inc. and Jamess Capital Group LLC",
"Amended and Restated Employment Agreement, by and between Relmada Therapeutics, Inc. and Sergio Traversa",
"Amended and Restated Employment Agreement, by and between Relmada Therapeutics, Inc. and Douglas Beck",
"Advisory and Consulting Agreement, by and between Relmada Therapeutics, Inc. and Sandesh Seth" |
|
| 07/16/2015 |
8-K
| Appointed a new director |
|
|